← Open Payments lookup

DAVID PAULSON: Open Payments

NPI 1740252196 · OREM, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$208 in 10 payments from 8 companies in 2025. Trend: 2023 $185 · 2024 $297 · 2025 $208

Food & beverage: $208
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$43
Supernus Pharmaceuticals, Inc.2$40
Alkermes, Inc.1$26
Lundbeck LLC1$26
Takeda Pharmaceuticals U.S.A., Inc.1$23
E.R. Squibb & Sons, L.L.C.1$18
ABBVIE INC.1$16
Tris Pharma Inc1$15

Products named: CAPLYTA, Qelbree, LYBALVI, REXULTI, TRINTELLIX, COBENFY, VRAYLAR, Dyanavel XR.

Industry payments across UT — which companies pay providers there.